Back to Search Start Over

Nektar Therapeutics Announces Multiple Presentations for Rezpegaldesleukin at EADV 2024

Source :
Plus Company Updates. September 26, 2024
Publication Year :
2024

Abstract

SAN FRANCISCO: Nektar Therapeutics has issued the following press release: Nektar Therapeutics (Nasdaq: NKTR) today announced several presentations for rezpegaldesleukin (REZPEG) at the 2024 European Academy of Dermatology and Venereology [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
Plus Company Updates
Publication Type :
News
Accession number :
edsgcl.810277088